Co-exposure to environmental cadmium and arsenic leads to kidney damage even at lower concentrations
The ATSDR 2019 Substance Priority List. 2019 [cited 2022 30 May]. Available from: https://www.atsdr.cdc.gov/programs/substance-priority-list.html?CDC_AAref_Val=https://www.atsdr.cdc.gov/spl/index.html.
Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ. Heavy metal toxicity and the environment. Exp Suppl. 2012;101:133–64.
Google Scholar
Bae HS, Ryu DY, Choi BS, Park JD. Urinary arsenic concentrations and their associated factors in Korean adults. Toxicol Res. 2013;29:137–42.
Google Scholar
Lee JS, Chon HT, Kim KW. Human risk assessment of As, Cd, Cu and Zn in the abandoned metal mine site. Environ Geochem Health. 2005;27:185–91.
Google Scholar
Ministry of Environment. 2021 White Paper of Environment. Seoul: Ministry of Environment. 2022.
Son HS, Kim SG, Suh BS, Park DU, Kim DS, Yu SD, et al. Association of cadmium with diabetes in middle-aged residents of abandoned metal mines: the first health effect surveillance for residents in abandoned metal mines. Ann Occup Environ Med. 2015;27:20.
Google Scholar
Grau-Pérez M, Kuo CC, Spratlen M, Thayer KA, Mendez MA, Hamman RF, et al. The association of arsenic exposure and metabolism with type 1 and type 2 diabetes in youth: The SEARCH case-control study. Diab Care. 2017;40:46–53.
Google Scholar
Chang CW, Wang CW, Wu DW, Lee WH, Chen YC, Liu YH, et al. Significant association between blood lead (Pb) level and haemoglobin A1c in non-diabetic population. Diab Metab. 2021;47:101233.
Google Scholar
Chen X, Wang Z, Zhu G, Liang Y, Jin T. Benchmark dose estimation of cadmium reference level for hypertension in a Chinese population. Environ Toxicol Pharmacol. 2015;39:208–12.
Google Scholar
Gambelunghe A, Sallsten G, Borné Y, Forsgard N, Hedblad B, Nilsson P, et al. Low-level exposure to lead, blood pressure, and hypertension in a population-based cohort. Environ Res. 2016;149:157–63.
Google Scholar
Zhao J, Li A, Mei Y, Zhou Q, Li Y, Li K, et al. The association of arsenic exposure with hypertension and blood pressure: a systematic review and dose-response meta-analysis. Environ Pollut. 2021;289:117914.
Google Scholar
Hyder O, Chung M, Cosgrove D, Herman JM, Li Z, Firoozmand A, et al. Cadmium exposure and liver disease among US adults. J Gastrointest Surg. 2013;17:1265–73.
Google Scholar
Frediani JK, Naioti EA, Vos MB, Figueroa J, Marsit CJ, Welsh JA. Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014. Environ Health. 2018;17:6.
Google Scholar
Seo MN, Eom SY, Lim JA, Lee JE, Choi BS, Kwon HJ, et al. Effects of environmental cadmium exposure on the liver in Korean adults: Cross-sectional and longitudinal studies. Arch Environ Contam Toxicol. 2023;84:237–47.
Google Scholar
Lin JL, Lin-Tan DT, Hsu KH, Yu CC. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med. 2003;348:277–86.
Google Scholar
Wu X, Liang Y, Jin T, Ye T, Kong Q, Wang Z, et al. Renal effects evolution in a Chinese population after reduction of cadmium exposure in rice. Environ Res. 2008;108:233–8.
Google Scholar
Cheng YY, Huang NC, Chang YT, Sung JM, Shen KH, Tsai CC, et al. Associations between arsenic in drinking water and the progression of chronic kidney disease: a nationwide study in Taiwan. J Hazard Mater. 2017;321:432–9.
Google Scholar
Wang G, Fowler BA. Roles of biomarkers in evaluating interactions among mixtures of lead, cadmium and arsenic. Toxicol Appl Pharm. 2008;233:92–9.
Google Scholar
Liu J, Liu Y, Habeebu SM, Waalkes MP, Klaassen CD. Chronic combined exposure to cadmium and arsenic exacerbates nephrotoxicity, particularly in metallothionein-I/II null mice. Toxicology. 2000;147:157–66.
Google Scholar
Hong F, Jin T, Zhang A. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population. Biometals. 2004;17:573–80.
Google Scholar
Nordberg GF, Jin T, Hong F, Zhang A, Buchet JP, Bernard A. Biomarkers of cadmium and arsenic interactions. Toxicol Appl Pharmacol. 2005;206:191–7.
Google Scholar
Diacomanolis V, Noller BN, Ng JC. Bioavailability and pharmacokinetics of arsenic are influenced by the presence of cadmium. Chemosphere. 2014;112:203–9.
Google Scholar
Hornung RW, Reed LD. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg. 1990;5:46–51.
Google Scholar
Bonsnes RW, Taussky HH. On the colorimetric determination of creatinine by the Jaffe reaction. J Biol Chem. 1945;158:581–91.
Google Scholar
van der Burgh AC, Rizopoulos D, Ikram MA, Hoorn EJ, Chaker L. Determinants of the evolution of kidney function with age. Kidney Int Rep. 2021;6:3054–63.
Google Scholar
Shankar A, Klein R, Klein BE. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol. 2006;164:263–71.
Google Scholar
Ishimura N, Inoue K, Maruyama S, Nakamura S, Kondo N. Income level and impaired kidney function among working adults in Japan. JAMA Health Forum. 2024;5:e235445.
Google Scholar
Huang M, Choi SJ, Kim DW, Kim NY, Park CH, Yu SD, et al. Risk assessment of low-level cadmium and arsenic on the kidney. J Toxicol Environ Health A. 2009;72:1493–8.
Google Scholar
Huang M, Choi SJ, Kim DW, Kim NY, Bae HS, Yu SD, et al. Evaluation of factors associated with cadmium exposure and kidney function in the general population. Environ Toxicol. 2013;28:563–70.
Google Scholar
Eom SY, Seo MN, Lee YS, Park KS, Hong YS, Sohn SJ, et al. Low-level environmental cadmium exposure induces kidney tubule damage in the general population of Korean adults. Arch Environ Contam Toxicol. 2017;73:401–9.
Google Scholar
WHO guidelines approved by the Guidelines Review Committee. In: WHO guideline for clinical management of exposure to lead. Geneva: World Health Organization; 2021.
World Health Organization. Office of Occupational Health. Biological monitoring of chemical exposure in the workplace: guidelines. Geneva: World Health Organization; 1996.
American Conference of Governmental Industrial Hygienists(ACGIH). TLVs® and BEIs®: based on the documentation of the threshold limit values for chemical substances and physical agents. Cincinnati, OH. 2022.
Poulik MD, Bernoco M, Bernoco D, Ceppellinni R. Aggregation of HL-A antigens at the lymphocyte surface induced by antiserum to beta2-microglobulin. Science. 1973;182:1352–5.
Google Scholar
Fu WJ, Xiong SL, Fang YG, Wen S, Chen ML, Deng RT, et al. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine. 2012;41:82–8.
Google Scholar
D’Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int. 2003;63:809–25.
Google Scholar
Shankland SJ. The podocyte’s response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006;69:2131–47.
Google Scholar
Orr SE, Bridges CC. Chronic kidney disease and exposure to nephrotoxic metals. Int J Mol Sci. 2017;18:1039.
Google Scholar
Balali-Mood M, Naseri K, Tahergorabi Z, Khazdair MR, Sadeghi M. Toxic mechanisms of five heavy metals: mercury, lead, chromium, cadmium, and arsenic. Front Pharmacol. 2021;12:643972.
Google Scholar
Qu F, Zheng W. Cadmium exposure: mechanisms and pathways of toxicity and implications for human health. Toxics. 2024;12:388.
Google Scholar
Ilyas K, Iqbal H, Akash MSH, Rehman K, Hussain A. Heavy metal exposure and metabolomics analysis: an emerging frontier in environmental health. Environ Sci Pollut Res. 2024;31:37963–87.
Google Scholar
link
